Sirnaomics unit RNAimmune Vaccine signs shareholder agreement with Guangzhou Guangjian fund for RMB 30 million investmentPUBT·1 day ago, 06:06 AM02257-7.62%
The Liquidity Bifurcation in Hong Kong: From Crypto Inverse Products to Micro-Cap AnomaliesGlobal Report·Aug 21 at 05:13 AM02617+2.63%016560.00%
Sirnaomics sues former executives over US$20 million TradArt investmentPUBT·Aug 14 at 08:01 AMTRAD0.00%02257-7.62%
Sirnaomics completes placement of 2,435,600 shares at HK$4.69 each, raising HK$11.3 million netPUBT·Aug 12 at 04:01 AM02257-7.62%
Medical and Hardware Rebound Signals Profit Reversals in Unclassified Hong Kong EquitiesGlobal Report·Aug 11 at 05:13 AM02252+2.60%02257-7.62%
Sirnaomics completes first patient dosing in Phase II trial of STP705 for medical aestheticsPUBT·Jul 30 at 04:17 AM02257-7.62%
Deal-Making and Debt: Inside the Fringes of the Hong Kong MarketGlobal Report·Jul 17 at 04:12 AM08305-1.61%01236+1.89%
The Hong Kong Market's Value Chain Bifurcation: From AI Infrastructure to Defensive YieldsGlobal Report·Jul 9 at 09:03 PM01666-1.68%02377-1.23%
The Unbundled Exchange: Capital Cycles and Value Chains in Hong Kong's Long TailGlobal Report·Jul 9 at 05:03 AM02233+3.69%02302+2.43%
